VA awards $186M for kidney dialysis centers, with Fresenius Medical Care Holdings Inc. as the primary contractor

Contract Overview

Contract Amount: $186,048,198 ($186.0M)

Contractor: Fresenius Medical Care Holdings Inc

Awarding Agency: Department of Veterans Affairs

Start Date: 2023-10-01

End Date: 2024-06-30

Contract Duration: 273 days

Daily Burn Rate: $681.5K/day

Competition Type: FULL AND OPEN COMPETITION

Pricing Type: FIRM FIXED PRICE

Sector: Healthcare

Official Description: EXPRESS REPORT: FY 24 1ST, 2ND, AND 3RD QUARTER NDSC

Place of Performance

Location: WALTHAM, MIDDLESEX County, MASSACHUSETTS, 02451

State: Massachusetts Government Spending

Plain-Language Summary

Department of Veterans Affairs obligated $186.0 million to FRESENIUS MEDICAL CARE HOLDINGS INC for work described as: EXPRESS REPORT: FY 24 1ST, 2ND, AND 3RD QUARTER NDSC Key points: 1. Contract awarded via full and open competition, suggesting a competitive bidding process. 2. The contract is a delivery order under an existing IDIQ contract, indicating a streamlined procurement approach. 3. Pricing is firm-fixed-price, which shifts cost risk to the contractor. 4. The contract duration is 273 days, suggesting a short-term or task-specific need. 5. The awardee, Fresenius Medical Care Holdings Inc., is a significant player in the healthcare sector. 6. The contract is for kidney dialysis centers, a critical healthcare service for veterans.

Value Assessment

Rating: good

The contract value of $186 million for a 273-day period for kidney dialysis centers appears substantial. Benchmarking against similar contracts for dialysis services is crucial to assess value for money. Given the firm-fixed-price structure, the VA is protected from cost overruns, but the overall cost-effectiveness will depend on the negotiated rates and the quality of services provided. The base award amount of $681,495 for the initial period suggests a significant portion of the total value is allocated to subsequent delivery orders.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

This contract was awarded under full and open competition, indicating that all responsible sources were permitted to submit offers. The specific number of bidders is not provided, but this procurement method generally fosters a competitive environment, which can lead to better pricing and service offerings for the government. The use of a delivery order under an existing contract suggests that a broader competition may have occurred previously for the underlying IDIQ contract.

Taxpayer Impact: Full and open competition is generally favorable for taxpayers as it maximizes the potential for competitive pricing and encourages a wider range of providers to offer their services, potentially leading to cost savings.

Public Impact

Veterans requiring kidney dialysis services will benefit directly from this contract. The contract ensures the continued provision of essential healthcare services for veterans with end-stage renal disease. The geographic impact is likely concentrated in areas where Fresenius Medical Care Holdings Inc. operates dialysis centers, potentially across multiple states. The contract supports healthcare professionals and support staff employed by Fresenius Medical Care Holdings Inc.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Potential for high concentration of services with a single large provider.
Dependence on a single contractor for a critical health service could pose risks if performance issues arise.

Positive Signals

Award to a well-established provider with significant experience in dialysis care.
Firm-fixed-price contract structure provides cost certainty for the government.
Awarded under full and open competition, suggesting a robust selection process.

Sector Analysis

The healthcare services sector, particularly specialized medical services like dialysis, is a significant area of federal spending. This contract falls within the broader category of healthcare services, specifically focusing on outpatient care centers. The market for dialysis services is characterized by a mix of large national providers and smaller regional or local facilities. Federal agencies like the VA often rely on established providers to ensure continuity and quality of care for beneficiaries.

Small Business Impact

The provided data does not indicate any specific small business set-aside provisions for this contract. As it is a delivery order under a larger contract, the small business participation may have been addressed at the IDIQ level or through subcontracting opportunities. Further analysis would be needed to determine the extent of small business involvement.

Oversight & Accountability

Oversight for this contract would typically be managed by the Department of Veterans Affairs contracting officers and program managers. The firm-fixed-price nature of the contract provides a degree of accountability regarding cost. Transparency would be enhanced by public reporting of contract performance and any associated quality metrics. Inspector General jurisdiction would apply in cases of fraud, waste, or abuse.

Related Government Programs

Medicare End-Stage Renal Disease (ESRD) Program
Medicaid ESRD Program
TRICARE
Other VA Healthcare Services Contracts

Risk Flags

Contract awarded as a delivery order under an existing IDIQ, requiring review of the parent contract's terms and competition.
Large contract value necessitates close monitoring of performance and cost-effectiveness.
Dependence on a single large provider for a critical health service.

Frequently Asked Questions

What is this federal contract paying for?

Department of Veterans Affairs awarded $186.0 million to FRESENIUS MEDICAL CARE HOLDINGS INC. EXPRESS REPORT: FY 24 1ST, 2ND, AND 3RD QUARTER NDSC

Who is the contractor on this award?

The obligated recipient is FRESENIUS MEDICAL CARE HOLDINGS INC.

Which agency awarded this contract?

Awarding agency: Department of Veterans Affairs (Department of Veterans Affairs).

What is the total obligated amount?

The obligated amount is $186.0 million.

What is the period of performance?

Start: 2023-10-01. End: 2024-06-30.

What is the historical spending pattern for kidney dialysis services by the Department of Veterans Affairs?

Analyzing historical spending on kidney dialysis services by the VA is crucial for understanding trends and budget allocation. While specific historical data for this exact contract is not provided, the VA consistently spends significant amounts on healthcare services for veterans, including those with chronic conditions like kidney disease. Past reports and budget documents would reveal fluctuations in spending based on veteran population needs, healthcare inflation, and procurement strategies. For instance, an increase in the veteran population requiring dialysis or the introduction of new treatment modalities could drive up spending. Conversely, efficiency improvements or shifts towards home-based dialysis could moderate costs. Understanding these patterns helps in forecasting future needs and evaluating the current contract's value in a long-term context.

How does the per-patient cost under this contract compare to Medicare or private insurance rates for dialysis?

Comparing the per-patient cost under this VA contract to Medicare or private insurance rates is essential for assessing value. While the raw contract value is $186 million, the actual per-patient cost depends on the number of veterans served and the frequency of treatments. Medicare's ESRD Prospective Payment System (PPS) sets reimbursement rates for dialysis, which can serve as a benchmark. Private insurance rates vary by region and provider. If the VA's negotiated rates are significantly higher than Medicare or comparable private insurance rates, it could indicate potential inefficiencies or a lack of aggressive price negotiation. Conversely, if the rates are lower, it might reflect the VA's purchasing power or specific service inclusions. Without detailed cost breakdowns per patient or per treatment session, a precise comparison is difficult, but the overall contract value provides a starting point for such an analysis.

What is Fresenius Medical Care Holdings Inc.'s track record with the VA and other federal agencies for similar services?

Fresenius Medical Care Holdings Inc. is a major provider of dialysis services globally and likely has a substantial track record with the VA and other federal entities. Assessing this track record involves reviewing past contract performance, including on-time delivery, quality of services, and any reported disputes or penalties. Federal procurement databases (like SAM.gov) and contract award histories can provide insights into their past awards, values, and performance ratings. A history of successful contract execution with the VA for dialysis or related healthcare services would be a positive indicator for this current award. Conversely, any significant performance issues or compliance problems on prior contracts could raise concerns about the reliability and effectiveness of this award.

What are the key performance indicators (KPIs) and quality metrics associated with this contract?

Key performance indicators (KPIs) and quality metrics are critical for ensuring the effectiveness and value of healthcare contracts. For kidney dialysis centers, these might include patient outcomes (e.g., mortality rates, hospitalization rates, fistula rates), adherence to treatment schedules, patient satisfaction scores, infection control rates, and compliance with clinical best practices. The contract documents should specify these KPIs and the methods for measuring and reporting them. The VA's ability to monitor and enforce these metrics will directly impact the quality of care veterans receive and the overall success of the contract. Without clearly defined and rigorously monitored KPIs, it is difficult to ascertain if the $186 million is being spent effectively to achieve desired health outcomes.

Are there any identified risks or challenges associated with this specific contract award or the contractor?

Potential risks associated with this contract include dependence on a single large provider, potential for service disruptions if the contractor faces operational issues, and ensuring consistent quality of care across all service locations. Given Fresenius's size, risks might also relate to market dominance and potential anti-competitive concerns, although this contract was awarded competitively. Challenges could arise from managing a large-value contract, ensuring compliance with VA regulations and healthcare standards, and adapting to evolving medical technologies or veteran needs. A thorough risk assessment would examine the contractor's financial stability, operational capacity, and historical performance in managing similar large-scale healthcare contracts.

Industry Classification

NAICS: Health Care and Social Assistance › Outpatient Care Centers › Kidney Dialysis Centers

Product/Service Code: MEDICAL SERVICES › OTHER MEDICAL SERVICES

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE

Pricing Type: FIRM FIXED PRICE (J)

Evaluated Preference: NONE

Contractor Details

Parent Company: Bio-Medical Applications of Missouri, Inc.

Address: 920 WINTER ST, WALTHAM, MA, 02451

Business Categories: Category Business, Corporate Entity Not Tax Exempt, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $186,048,198

Exercised Options: $186,048,198

Current Obligation: $186,048,198

Contract Characteristics

Multi-Year Contract: Yes

Commercial Item: COMMERCIAL PRODUCTS/SERVICES

Cost or Pricing Data: NO

Parent Contract

Parent Award PIID: 36C79119D0021

IDV Type: IDC

Timeline